NCT03331965View on ClinicalTrials.gov

Metoclopramide Versus Placebo for GJ Placement

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

April 9, 2018

Primary Completion Date

October 3, 2019

Study Completion Date

October 3, 2019

Conditions
Radiation ExposureEnteral Nutrition
Interventions
DRUG

Metoclopramide 5 MG/ML Injectable Solution

A one-time dose of promotility agent (metoclopramide 10 mg in 10 mL saline IV) will be administered at the time of GJ placement.

DRUG

Saline

A one-time dose of a placebo (10 mL saline IV) will be administered at the time of GJ placement.

Trial Locations (1)

27710

Duke University Hospital, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER